CymitQuimica logo

Blonanserin

CAS:

Ref. 3D-FB18840

50mg
863.00€
Blonanserin
Biosynth

    Product Information

    Name:Blonanserin
    Controlled Product
    Synonyms:
    • LonasenAD 54232-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine
    Brand:Biosynth
    Description:Blonanserin is a drug for the treatment of congestive heart failure. It is a potent and selective antagonist of 5-HT2A receptors. Blonanserin was shown to increase serum prolactin levels in humans, and has been shown to decrease locomotor activity in rats. The effects on locomotor activity are not due to its effect on dopamine or serotonin levels, but may be caused by its matrix effect on 5-HT2A receptors. The long-term efficacy of blonanserin has been demonstrated by the fact that it can be used as a pharmacological treatment for Parkinson's disease and schizophrenia.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:367.5 g/mol
    Formula:C23H30FN3
    Purity:Min. 95%
    InChI:InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3
    InChI key:InChIKey=XVGOZDAJGBALKS-UHFFFAOYSA-N
    SMILES:CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1

    Technical inquiry about: Blonanserin

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.